• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Buildings and Facilities

<< Return to FY 2006 Budget Summary


  FY 2004 Actual FY 2005 Enacted FY 2006 Estimate Increase or Decrease

Program Level

$22,504,000 $0 $7,000,000 +$7,000,000

Budget Authority

$22,504,000 $0 $7,000,000 +$7,000,000


Historical Funding and FTE Levels
Fiscal Year Program Level Budget Authority User Fees Program Level FTE
2002 Actual 1/ $43,867,000 $43,867,000 $0 0
2003 Actual $17,043,000 $17,043,000 $0 0
2004 Actual $22,504,000 $22,504,000 $0 0
2005 Enacted $0 $0 $0 0
2006 Estimate $7,000,000 $7,000,000 $0 0

1/Includes FDA's FY 2002 Appropriation and the Counterterrorism Supplemental.


Statement of Budget Request


The Agency is requesting $7,000,000 in program level resources for accomplishing its mission activities. This appropriation would provide funding for new construction and needed repairs and improvements which include Maryland site components which are now located in approximately 40 buildings in 16 separate locations; plus five regional offices, 19 field District complexes including 19 administrative and 13 specialized laboratory facilities nationwide; more than 120 field resident posts, eight field criminal investigation offices, two distinct program laboratory complexes outside the Washington D.C. Metro area; and the NCTR complex in Jefferson Arkansas. Overall, FDA maintains offices and staff in 49 states, and in the District of Columbia and Puerto Rico.


Program Description

The Building and Facilities appropriation provides funding for new construction and for needed repairs and improvements to existing facilities across the U.S.


Program Resource Changes - Program Account Restructuring


GSA Rent and Other Rent Activities Structure Change

To provide increased flexibility and accountability, eliminate the need for the many reprogramming requests to the Congress, place the accountability for rental costs within the operating program, and would better reflect the total cost of each program. This budget changes the way the GSA Rent and Other Rent-Related Activities budget lines are displayed by incorporating these resources into program level requests.


Office of Regulatory Affairs Estimate and Structure Change

This budget also establishes a single budget line item for the Office of Regulatory Affairs (ORA). To help the field program provide services more effectively, especially by providing much needed flexibility to respond shifting program priorities. This additional flexibility is essential to allow FDA to respond to emerging situations without being hindered in performing its mission critical activities. These activities have been removed from each program line and the Field estimates will be provided under the Office of Regulatory Affairs to reflect the planned spending for each program area.


FDA White Oak Consolidation Structure Change

To provide increased flexibility and to better reflect the total cost of the White Oak Consolidation effort, this budget changes the way the budget line is displayed by adding an individual line to display the consolidation project.


Budget Authority


Buildings and Facilities: +$7,000,000

Managing a nationwide inventory of leased and owned real property assets that include a substantial amount of lab facilities requires regular repair, improvement and maintenance activities on a preventative and, on an emergency basis. Modifying these spaces to accommodate programs and maintain the buildings as they age allows FDA employees to perform their duties in a safe, healthful and productive work place.

Without funding in FY 2006, FDA will delay completion of projects, which will cause additional operating costs to support personnel and equipment in different buildings and postponing planned inter-center research projects. FDA could be in a position of having to shut-down laboratories and buildings due to safety issues, with field operations bearing the brunt of any such closures. Restoration is especially important, and not receiving the requested resources could lead to rising costs due to the continued delays in maintenance and deterioration of the FDA facilities.

Based on the appropriated funding for FY 2006 the listed projects will be prioritized and initiated based on the greatest need:


ORA, Nationwide - Miscellaneous Repair and Improvement


CFSAN, Dauphin Island, AL and College Park, MD - Miscellaneous Repair and Improvement


CDER, Montgomery County, MD - Anticipated changes, fixed equipment installation and modifications to existing space associated with realignment and consolidation


CBER, Bethesda, MD - Miscellaneous Repair and Improvement


CDRH, Rockville, MD - Anticipated changes, fixed equipment installation and modifications to existing space associated with realignment and consolidation


CVM, Laurel, MD - Miscellaneous Repair and Improvement to Veterinary Medicine buildings


NCTR, Jefferson, AR - Miscellaneous Renovation, Repair and Improvement


Headquarters - Implementation of Enterprise Asset Management System


Federal Building 8, Washington, D.C. - Decommissioning of laboratory

TOTAL $25,441,000

The Building and Facilities needs total $33,641,000 of which $8,200,000 are line item request for WEAC and ARL.


Justification of Base - Improving FDA'S Business Practices


Through improving FDA's business practices, the Agency will ensure a world-class professional work force, effective and efficient operations and adequate resources to accomplish the mission.


Status Of Major Projects


White Oak

The White Oak Consolidation Program continues its coordinated efforts to execute the 2000 Master Plan design to provide a new state of the art facility for the FDA at White Oak.

On December 11, 2003, a dedication ceremony was held for the Life Sciences Laboratory, a state of the art chemistry, bioscience and animal research facility. As the first new building to open on the site, the laboratory provides approximately 124,000 gross square feet, for 120 employees from the Center for Drug Evaluation and Research (CDER) and the Center for Devices and Radiological Health (CDRH).

Construction for the CDER Office Building I began on November 15, 2002, and has progressed on schedule for occupancy in spring 2005. This building provides 560,000 gross square feet of modern office space to accommodate the Office of New Drugs, comprised of approximately 1,700 scientists and support staff. The facility also includes a 60,000 square foot, efficient document storage center, mail room and support space.

Construction of the Central Shared Use Building began in October 2004. When complete this facility will provide employees and visitors with a cafeteria, conference and training center, credit union, fitness center, health unit, central library and R&W store, along with housing the Agency security command center, central data center and NTEU offices. The first phase of this building, including the cafeteria, fitness center and security command center, is scheduled for completion in spring 2006.

The CDRH Engineering/Physics Laboratory construction contract was awarded in January 2005 with construction completion expected in February 2007. This building will provide approximately 128,000 square feet of high tech laboratories engaged in evaluating electromagnetic and medical devices, radiological instruments and consumer appliances generating radiological signals. The facility consists of numerous vibration isolation slabs, electromagnet shielding, an anechoic chamber and laser devices especially dedicated to the program science. This facility is scheduled for occupancy in 2006.

With design to be complete in spring 2005, the approximately 291,000 gross square foot, CDER Office Building II will accommodate the Center Director's office and the balance of the CDER scientific and support staffs. This is a uniquely designed office building in that the entire building will be equipped with an under-floor ventilation system. This design change provides for more offices benefiting from indirect outside daylight, taller windows, more efficient distribution of air and electrical wiring along with IT/Telecom and security wiring.

Finally, the first phase of the site's parking garages is at the 75% design level with the start of construction planned for 2005. This concrete parking structure will contribute approximately 800 spaces to the overall parking for the campus.


Arkansas Regional Laboratory (ARL)

As a part of FDA's plan to restructure its eighteen field laboratories, ARL is one of five multi-disciplined laboratories and will provide laboratory support for a seventeen statewide area and for the U.S-Mexican border stretching from Otay Mesa, California to Brownsville, Texas. The ARL provides analytical support in chemistry and microbiology. The ARL scientists are testing products regulated by the FDA to ensure compliance with the FFDCA, which will include products produced in the U.S. and imported.


Winchester Engineering and Analytical Center:

The Winchester Engineering and Analytical Center (WEAC) located in Winchester, MA, serves as a national resource for evaluation of radiological and other medical devices. WEAC is the only FDA facility that provides specialized engineering and analytical services and radionuclide analysis. This laboratory was constructed in 1952, is in poor condition, and cannot be adequately renovated to meet modern laboratory standards.


<< Return to FY 2006 Budget Summary